Location History:
- Cincinnati, OH (US) (2002 - 2009)
- Clarksville, MD (US) (2010 - 2014)
Company Filing History:
9 out of 532 
4 out of 1,379 
2 out of 10 Years Active: 2002-2014
Title: Stephen Bryant Liggett: An Innovator in Cardiovascular and Central Nervous System Disease Treatment
Introduction:
Stephen Bryant Liggett, based in Cincinnati, OH, is a prolific inventor who has made significant contributions in the field of healthcare and medical research. With nine patents to his name, Liggett has shown a strong commitment to improving the diagnosis, prognosis, and treatment of cardiovascular and central nervous system diseases. This article delves into Liggett's latest patents, his notable affiliations, and some of his esteemed colleagues.
Latest Patents:
Liggett's recent patents showcase his expertise in genetic variations related to alpha-2 adrenergic receptors and beta-blocker therapy. Through identifying and utilizing polymorphisms in nucleic acids that encode alpha-2B, alpha-2A, and alpha-2C adrenergic receptors, his inventions have paved the way for improved disease detection, diagnosis, and treatment. These breakthroughs hold significant implications for cardiovascular and central nervous system diseases.
In Liggett's patent on alpha-2 adrenergic receptor polymorphisms, he demonstrates the use of specific molecules and methods for identifying these genetic variations. By predicting the relative efficacy of beta-blocker therapies based on B1-adrenergic receptor polymorphisms, Liggett's inventions contribute to personalized medicine, ensuring patients receive optimal treatment plans.
Career and Affiliations:
Stephen Bryant Liggett has worked with esteemed institutions that have facilitated his groundbreaking research. He made impactful contributions during his association with the University of Cincinnati, where he likely conducted comprehensive research and collaborated with fellow scientists. Liggett has also worked with Genaissance Pharmaceuticals, Inc., a notable biopharmaceutical company that focuses on utilizing genetics to develop personalized treatments.
Notable Colleagues:
Throughout his journey, Liggett has collaborated with several experts in the field. Among his colleagues are Kersten M Small and Lynne Elizabeth Wagoner, both of whom have likely played instrumental roles in the conception and development of his inventions. These collaborations underscore Liggett's ability to work effectively within multidisciplinary teams to bring innovative ideas to fruition.
Conclusion:
Stephen Bryant Liggett's contributions to the field of healthcare and medical research are truly remarkable. His patents on alpha-2 adrenergic receptor polymorphisms and genetic variations associated with beta-blocker therapy demonstrate his commitment to advancing personalized medicine for cardiovascular and central nervous system diseases. Liggett's association with prestigious organizations and collaborations with accomplished colleagues only further solidify his position as a leading innovator in the field. His work undoubtedly continues to drive advancements in the diagnosis, prognosis, and treatment of various diseases, benefiting patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.